Skip to main content
. 2025 Oct 21;17:729–742. doi: 10.2147/CEOR.S532071

Table 3.

Humanistic Burden

Author/Year Study Details Questionnaire Used Instrument Measurement Observations
Feuerstein (2019)83
  • US

  • Cohort study

  • Patients with MIBC scheduled for RC

  • Data collected within 4 weeks of scheduled RC

  • N=155

  • EORTC-QLQ-C30

  • EORTC-QLQ-BLM30

  • HRQOL for patients treated with NAC prior to RC

  • No significant difference regarding general HRQOL between NAC-treated and untreated patients prior to RC

  • Marginally better emotional and mental health in patients with vs without NAC

Kretschmer (2020)84
  • Germany

  • Prospective cohort study

  • Patients with MIBC undergoing RC (IC and ONB)

  • Follow-up data collected 3, 12, and 24 months after RC

  • N=134

  • EORTC-QLQ-C30

  • Quality of life of cancer patients

  • 2 years postoperatively general HRQOL was greater in the ONB patient cohort compared with the IC cohort

  • Good general HRQOL was reached by 32.4% of patients in the IC cohort and 61.1% of patients in the ONB cohort

  • Significantly better physical and role functioning in the ONB patient cohort in comparison with the IC cohort

Schulz (2021)85
  • Germany

  • Cohort study

  • Patients with MIBC undergoing RC (IC and ONB)

  • Follow-up period from 3 months to 12 years after receiving RC

  • N=280

  • EORTC-QLQ-C30

  • ICIQ-SF

  • Impact of symptoms of incontinence on outcome

  • Decision regret was reported among the ONB patient cohort following ONB urinary diversion. This was reported between the 4- and 6-year time points, without any correlation with general HRQOL

Volz (2022)86
  • Germany

  • Cohort study

  • Patients with MIBC scheduled for RC (IC and ONB)

  • Data collected preoperatively and at 3, 12, 24, 36, and 48 months of follow-up

  • N=246

  • EORTC-QLQ-C30

  • EORTC-QLQ-BLM-30

  • FACT-Bl

  • Quality of life of cancer patients

  • Impact of RC and reconstructive surgery in terms of HRQOL

  • Bladder cancer-specific symptoms

  • No statistical differences between IC and ONB patient cohorts postoperatively in terms of EORTC-QLQ-BLM-30 assessments

  • Significant differences between IC and ONB patient cohorts regarding preoperative EORTC-QLQ-C30 symptoms and functioning scores were reported including increased fatigue and appetite loss, which diminished during the postoperative time course

  • No significant differences across IC and ONB patients at various time points, up to 48 months

Bahlburg (2023)87
  • Germany

  • Cohort study

  • Patients who had received RC and now receiving inpatient rehabilitation after RC (IC and ONB)

  • Follow-up data collected 4 weeks, 6 and 12 months after RC

  • N=842

  • QSC-R10

  • EORTC-QLQ-C30

  • EORTC-QLQ-BLM-30

  • Psychosocial distress and quality of life in cancer patients

  • HRQOL improved during follow-up after RC

  • An average of 40% of all participants (consisting of IC and ONB cohorts) reported high psychosocial distress at all time points, up to 1 year

Abbreviations: EORTC-QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; EORTC-QLQ-BLM-30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Muscle-Invasive Bladder Cancer 30; FACT-Bl, Functional Assessment of Cancer Therapy–Bladder; HRQOL, health-related quality of life; IC, ileal conduit; ICIQ-UI SF, International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form; MIBC, muscle-invasive bladder cancer; NAC, neoadjuvant chemotherapy; ONB, orthotopic neobladder; QSC-R10, Questionnaire on Stress in Cancer Patients; RC, radical cystectomy.